BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 28, 2019
View Archived Issues
Nitric oxide-scavenging nanogel suppresses onset of rheumatoid arthritis in vivo
Read More
Cell wall component causes trouble in Lyme disease
Read More
Going down in flames improves antitumor immunity
Read More
Novel protein-coding gene is key to intestinal development
Read More
Mutations in SSBP1 gene cause a form of optic atrophy with mitochondrial depletion
Read More
Metabolic enzyme targeting takes on pulmonary hypertension
Read More
[64Cu]Cu(SarbisPSMA): a bifunctional PSMA ligand for developing PSMA-targeted theranostics
Read More
Interim analysis of phase III CASPIAN trial shows improvement in OS in patients treated with Imfinzi
Read More
Ovid Therapeutics initiates phase III NEPTUNE trial
Read More
Wave Life Sciences initiates DYSTANCE 51 phase II/III study of suvodirsen
Read More
Updated phase II data for camrelizumab combination treatment in advanced G/GEJ cancer
Read More
Phase I results for fluzoparib in combination with apatinib and paclitaxel in gastric cancer
Read More
Researchers link LIG3 mutations to mitochondrial neurogastrointestinal encephalomyopathy
Read More
Avaliv Therapeutics divulges new cathepsin D inhibitors
Read More
Arena Pharmaceuticals divulges beta3-adrenoceptor antagonists
Read More
Sage Therapeutics identifies GABA-A receptor modulators
Read More
Galapagos identifies new compounds for HBV
Read More
Array BioPharma divulges TAM receptor tyrosine kinases inhibitors
Read More
Vaccibody reports immunogenicity data from cancer patients treated with VB10.NEO
Read More
CD28 unveiled as potential therapeutic target for giant-cell arteritis
Read More
LSK BioPharma reports topline data from phase III study of rivoceranib in advanced gastric cancer
Read More
FDA approves Doptelet for chronic immune thrombocytopenia
Read More
Darzalex approved by FDA for newly diagnosed multiple myeloma ineligible for ASCT
Read More
Phase I/II LuPIN trial of [177Lu]PSMA-617 and NOX-66 in men with mCRPC shows early signs of efficacy
Read More
FDA approves Soliris for neuromyelitis optica spectrum disorder
Read More
Advaxis to close AIM2CERV trial, focus resources on neoantigen-directed immunotherapies
Read More
Verrica initiates phase II study of VP-102 for genital warts
Read More
BioCryst opens enrollment in phase I study of oral factor D inhibitor BCX-9930
Read More
Ziopharm initiates phase II trial of Controlled IL-12 with cemiplimab in recurrent GBM
Read More
ImmuPharma reports open-label extension study results for Lupuzor in SLE
Read More